estradiol, 25 mcg

Phase 3Completed
0 watching 0 views this week๐Ÿ“ˆ Rising
76
Hype Score

Development Stage

โœ“
Pre-clinical
โœ“
Phase 1
โœ“
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Menopause

Conditions

Menopause, Postmenopausal Vaginal Atrophy

Trial Timeline

Jan 31, 1995 โ†’ Nov 30, 1996

About estradiol, 25 mcg

estradiol, 25 mcg is a phase 3 stage product being developed by Novo Nordisk for Menopause. The current trial status is completed. This product is registered under clinical trial identifier NCT00464971. Target conditions include Menopause, Postmenopausal Vaginal Atrophy.

Hype Score Breakdown

Clinical
27
Activity
18
Company
9
Novelty
9
Community
10

Clinical Trials (3)

NCT IDPhaseStatus
NCT01507454Pre-clinicalCompleted
NCT00560924Phase 3Terminated
NCT00464971Phase 3Completed